Motivyst Tablet
Marketer
Janssen Pharmaceuticals
Salt Composition
Canagliflozin (300mg)
Overview Motivyst Tablet
Diabetol tablets are indicated for monotherapy or combination therapy in managing type 2 diabetes. They effectively regulate elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular protection. Diabetol can be administered with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuation should only occur under medical supervision; abrupt cessation may lead to hyperglycemia and potentially serious consequences such as renal impairment or vision loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight control, as directed by your doctor. Commonly reported adverse effects include vaginal yeast infections, urinary tract infections, and urinary frequency. Excessive diuresis is possible; adequate hydration is crucial to prevent dehydration. Practicing meticulous hygiene can help minimize genital fungal infections. Prior to initiating treatment, disclose any kidney or liver dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Limit alcohol consumption during treatment to minimize potential side effects. Regular blood glucose monitoring is essential during therapy.
Uses of Motivyst Tablet
Managing type 2 diabetes
Major Benefits of Motivyst Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Motivyst Tablet on an empty stomach.
Common Side effects of Motivyst Tablet:
- Increased thirst
- Polyuria
- Urinary tract infection
- Genital fungal infection
- Nausea
- Constipation
- Rash
How to use Motivyst Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Motivyst Tablet on an empty stomach.
How Motivyst Tablet works:
GlucoRegul tablets help manage diabetes by facilitating the excretion of surplus glucose via urinary elimination.
SAFETY ADVICE
AlcoholUNSAFE
Combining Motivyst tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnant women should exercise caution with Motivyst Tablet. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the risks and benefits prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Motivyst Tablet while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Motivyst Tablet. Nevertheless, instances of dizziness or lightheadedness have been documented, potentially impairing the safe operation of vehicles, bicycles, or machinery.
KidneyCAUTION
Caution is advised when prescribing Motivyst Tablet to individuals with kidney disease; dosage modification may be necessary. Physician consultation is recommended. Dosage alteration isn't required for those with mild kidney dysfunction; however, Motivyst Tablet is contraindicated in patients with severe kidney impairment or those receiving dialysis.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely take Motivyst Tablets without any necessary dosage modification. Dosage adjustments are unnecessary for those with mild to moderate liver impairment; however, Motivyst Tablets are contraindicated in patients with severe hepatic impairment.
What if you forget to take Motivyst Tablet :
Should you forget a Motivyst Tablet dose, ingest it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Motivyst Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



